2317 related articles for article (PubMed ID: 820004)
1. Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?
Hill GJ; Johnson RO; Metter G; Wilson WL; Davis HL; Grage T; Fletcher WS; Golomb FM; Cruz AB
Surg Gynecol Obstet; 1976 Jun; 142(6):882-92. PubMed ID: 820004
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy for carcinoma of the colon and rectum.
Higgins GA
Int Adv Surg Oncol; 1984; 7():77-111. PubMed ID: 6469380
[TBL] [Abstract][Full Text] [Related]
3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
4. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
Carter RD; Krementz ET; Hill GJ; Metter GE; Fletcher WS; Golomb FM; Grage TB; Minton JP; Sparks FC
Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil (NSC-19893), DTIC (NSC-45388), BCNU (NSC-409962), and vincristine (NSC-67574) in advanced colorectal carcinoma.
von Eyben FE; Larsen V; Pedersen H
Cancer Treat Rep; 1976 Jan; 60(1):29-32. PubMed ID: 1000517
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy in alimentary tract malignomas.
Queisser W; Heim ME
Hepatogastroenterology; 1981 Oct; 28(5):276-83. PubMed ID: 6212524
[No Abstract] [Full Text] [Related]
7. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.
Collette L; Bosset JF; den Dulk M; Nguyen F; Mineur L; Maingon P; Radosevic-Jelic L; Piérart M; Calais G;
J Clin Oncol; 2007 Oct; 25(28):4379-86. PubMed ID: 17906203
[TBL] [Abstract][Full Text] [Related]
8. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy for resectable rectal and colonic cancer.
Heriot AG; Kumar D
Br J Surg; 1998 Mar; 85(3):300-9. PubMed ID: 9529480
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and surgical treatment of metastatic lung tumors].
Yamamoto Y; Hirata T; Fukuse T; Yokomise H; Ike O; Mizuno H; Wada H; Hitomi S; Nakamura T; Shimizu Y
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1248-54. PubMed ID: 8831735
[TBL] [Abstract][Full Text] [Related]
12. [Background and experience of adjuvant cytostatic therapy in gastrointestinal cancer (author's transl)].
Hafström L; Bengmark S; Eriksson S; Hugander A
Zentralbl Chir; 1981; 106(19):1284-8. PubMed ID: 7034399
[TBL] [Abstract][Full Text] [Related]
13. Randomized, comparative study of high-dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for patients with operable stage II or III breast cancer involving 10 or more axillary lymph nodes (CALGB Protocol 9082). Cancer and Leukemia Group B.
Hurd DD; Peters WP
J Natl Cancer Inst Monogr; 1995; (19):41-4. PubMed ID: 7577204
[TBL] [Abstract][Full Text] [Related]
14. Effective adjuvant treatments. A brief review of U.S. clinical trials.
Louie AC; Rozencweig M; von Hoff DD; Muggia FM
Arch Geschwulstforsch; 1978; 48(7):653-8. PubMed ID: 282826
[TBL] [Abstract][Full Text] [Related]
15. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
16. Non-cross-resistant chemotherapy and consolidation radiotherapy for small cell carcinoma of the lung.
Young JA; Dillman RO; Seagren SL; Taetle R; Rentschler RE; Lea JW; Lehar TJ; Green MR; Stanton W; Mendelsohn J; Royston I
Cancer Treat Rep; 1982 Jun; 66(6):1399-401. PubMed ID: 6282459
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy in colorectal cancer.
Gerard A; Metzger U; Buyse M
Anticancer Res; 1989; 9(4):1033-5. PubMed ID: 2683989
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy of cancer of the large intestine].
Platinskiĭ LV; Sokolova VD; Ozhiganov EL
Sov Med; 1985; (3):51-8. PubMed ID: 3895460
[No Abstract] [Full Text] [Related]
19. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
Agarwala SS; Neuberg D; Park Y; Kirkwood JM
Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
[TBL] [Abstract][Full Text] [Related]
20. [Combined therapy of tumors in adults].
Schmitt G; Arndt D; Hossfeld KD
Strahlenther Onkol; 1986 Feb; 162(2):93-9. PubMed ID: 3006269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
